Sanofi
ANTI-CHIKV ANTIBODIES AND USES THEREOF
Last updated:
Abstract:
The present invention concerns antibodies and antigen-binding fragments of antibodies which specifically bind to and neutralize Chikungunya virus (CHIKV) and which are engineered to develop therapeutics in order to treat CHIKV disease or prevent CHIKV infection. The invention also relates to pharmaceutical compositions comprising antibodies of the invention and the use of the antibodies for the prevention and treatment of CHIKV disease.
Status:
Application
Type:
Utility
Filling date:
16 Feb 2022
Issue date:
1 Sep 2022